Trial
NCT02161419
RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bayer
Collaborators
—
Condition
Small Cell Lung Carcinoma
Intervention
Roniciclib (BAY1000394)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-06-25